Bruno Ehrler, BSc, B.ENG, LIC., MBA, Chief Executive Officer

Before stepping into his role as Chief Executive Officer of 1CryoBio AG, Bruno Ehrler practiced as an Industrial Engineer and Six Sigma Voice-of-the-Customer Champion in several industries. He has held full responsibility for multi-million dollar projects executed with international cross-functional teams. In addition, Bruno holds an MBA from the University of St. Gallen, brings experience of start-up businesses and has proven his leadership in various fields.
Bruno Ehrler on LinkedIn.

Ove Andersen, MD, PhD, Chief Technical Officer

Dr. Andersen is a specialist in Internal Medicine and Infectious Diseases and serves Clinical Associate Professor at Copenhagen University. Dr. Andersen is also Head of the Clinical Research Centre at the Copenhagen University Hospital Hvidovre. Dr. Andersen is co-author of more than 90 scientific publications and is inventor and co-inventor of four patents, several products based on which have reached the market. Dr. Andersen has commercialization experience as founder of Profylakse Aps and Oracain Aps, were he was in charge of scientific and clinical studies, with responsibility for management and design of trials, product design and overall co-ordination of the development programs.
Ove Andersen on LinkedIn.

Georgios Georgopoulos, BSc, MBA, Business Development Manager

Georgios has studied Physics at the Univerity of Athens and holds an MBA from the University of St. Gallen. He has long experience in sales and marketing in various fields of the life sciences industry (diagnostics, pharma, biotech, med-tech) and in several company types (SME’s, startups, global corporations). In 1CryoBio Georgios is in charge of the commercial operations of the company.
Georgios Georgopoulos on LinkedIn.